Novartis Home

September is Blood Cancer Awareness Month

Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

We are reimagining medicine to power breakthrough innovation in cell and gene therapy

Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy.